StatCounter
Archives
-
-
http://geekandmode.wordpress.comcongrats pour l'ensemble de ton blog... je te suis depuis peu et je trouve tes posts de qualité! J'é
- BLOGSCAN – An Ex-Pharmaceutical Company CEO to Run the American College of Cardiology? | ancientromangames[...] Mann’s blog discussed the appointment of a former pharmaceutical company executive, most
-
marilynmannTracy Thanks, but I decline the offer. Best Marilyn
-
Tracy RoseHi, Healthline is interested in contributing a guest post to marilynmann.wordpress.com. We would be
-
datasharing « Gezond leven in een kakofonie[...] http://marilynmann.wordpress.com/2012/04/11/more-on-the-need-for-data-sharing-the-tamiflu-exam
-
datasharing « Gezond leven in een kakofonie[...] my previous post on the need for data sharing. For the past three years, a group of researche
-
Ik weet het niet zeker « fromcontributiontoindependence[...] wat wij weten over de werking van geneesmiddelen, de effectiviteit en de veiligheid. Zie ook d
- BMJ editor: Open letter to Roche about oseltamavir trial data « Marilyn Mann's Blog[...] Background here. [...]
- Heart and Stroke Foundation “make death wait” campaign: effective advocacy or unnecessary scare tactics? (9)
- Abbott Laboratories sponsors review article on its own drug (8)
- More on the need for data sharing — the Tamiflu example (7)
- Hayward and Krumholz: Open Letter to the Adult Treatment Panel IV of the National Institutes of Health (7)
- Data sharing as a moral imperative (5)
- Sunday links (5)
- FDA warns Chantix may increase risk of cardiovascular events (4)
- Why the new indication for Vytorin and Zetia should not be approved (3)
- Compare and contrast: two review articles on ezetimibe (3)
- Profile on Harlan Krumholz (3)
- April 2013 (1)
- October 2012 (4)
- September 2012 (1)
- August 2012 (1)
- July 2012 (1)
- June 2012 (1)
- May 2012 (4)
- April 2012 (5)
- March 2012 (2)
- February 2012 (2)
- January 2012 (2)
- December 2011 (1)
- November 2011 (2)
- September 2011 (3)
- August 2011 (1)
- July 2011 (4)
- June 2011 (3)
- May 2011 (1)
- February 2011 (1)
- November 2010 (1)
- October 2010 (3)
- May 2010 (1)
American College of Cardiology ATP IV Avandia cardiology cardiovascular risk cholesterol conflicts of interest Consumer Reports data sharing David Rind Dean Follmann drug safety EBM Ellis Unger ezetimibe Harlan Krumholz health care costs heart attacks heart disease Joseph Ross Kevin Lomangino lipids Merck Meridia Milton Packer open science Peter Doshi plant sterols portfolio diet publication bias relationships with industry Rodney Hayward rofecoxib rosiglitazone Sanjay Kaul SHARP trial sibutramine statins Steve Nissen Tamiflu Tom Jefferson treat to target Vioxx Vytorin Zetia- cardiology (23)
- plant sterols (3)
- conflicts of interest (3)
- data sharing (6)
- drug safety (10)
- health care (3)
- health care costs (1)
- medical device safety (2)
- politics (1)
- scholarly journals (4)
- Uncategorized (8)
-
Blogroll
- 1 Boring Old Man
- A Dose of History
- A New Merck: Reviewed
- Adam G. Dunn
- Ase Fixes Science
- Avian Flu Diary
- Bad Science
- Ben Goldacre — secondary blog
- Benoit Bisson
- CardioBrief
- Common Sense Family Doctor
- Doctor David's Blog
- Evidence in Medicine
- Evidence Live Blog
- Evidently Cochrane
- Fear and Loathing in Bioethics
- Gooznews
- Harlan Krumholz Outcomes blog
- Health Care Basics
- Health Care Renewal
- Health News Watchdog blog
- HealthLawProf Blog
- Hooked: Ethics, Medicine, and Pharma
- IP Policy Committee blog
- Kentucky Health Policy Institute blog
- KevinMD
- Laika's MedLibLog
- Managing Healthcare Costs
- mathbabe
- Medicine and Social Justice
- milescorak: Economics for public policy
- Minimally Disruptive Medicine
- Neurologica Blog
- Neuroskeptic
- Not Running a Hospital
- Now@NEJM
- nutsci.org Nutritional Science!
- Occupy Healthcare
- Open Medicine EU
- Open Science
- Patient POV
- Pharmacritique
- Pharmagossip
- Pharmalot
- Pizaazz
- Points from Pronovost
- Postscript
- Regina Holliday's Medical Advocacy Blog
- Respectful Insolence
- Rethink Aid
- Richard Lehman's Journal Review
- Robert M. Califf, MD
- Science-Based Medicine
- Science-Based Pharmacy
- Speaking of Medicine
- Statistically funny
- The Beating Edge
- The Carlat Psychiatry Blog
- The File Drawer
- The Incidental Economist
- The Lab @ Edmond J. Safra Center for Ethics – Blog
- The Medicine Show
- Thought Broadcast
- To Conquer Confusion
- University Diaries
- Weighty Matters
- White Coat Underground
- Whole Health Source
Links
- All Trials
- Bad Guidelines
- BMJ Open Data Campaign
- Familial Hypercholesterolemia Discussion Group
- Foundation for Integrity and Responsibility in Medicine
- Healthy Skepticism
- Healthy Skepticism UK
- National Physicians Alliance
- PATH (Publish All Trials on Humans)
- PharmedOut
- Sense About Science
- Society for Participatory Medicine
Search
Sitemeter
-
Recent posts
- Should a former drug company executive be CEO of the American College of Cardiology?
- BMJ: Clinical trial data for all drugs in current use must be available for independent scrutiny
- BMJ editor: Open letter to Roche about oseltamivir trial data
- Ben Goldacre on missing data and publication bias
- Johns Hopkins to launch Center for Drug Safety and Effectiveness
- Article in Korean Circulation Journal retracted for plagiarism
- Women vote
- Compare and contrast: two review articles on ezetimibe
- Alzheimer’s disease, familial hypercholesterolemia, and clinical trials
- “Be Brave”
- More information on the PharmedOut conference
- Third Annual PharmedOut Conference
- More commentaries on data sharing
- Krumholz: “I think maybe we have a chance to turn the world upside down just a bit”
- Harvard Faculty Advisory Council: cost of journals “prohibitive,” situation “untenable”
- The “thermostat model” of health care utilization
- Lauer: is Qnexa a lemon or a peach?
- More on the need for data sharing — the Tamiflu example
- Data sharing as a moral imperative
- CardioBrief: “A Case of Plagiarism Raises Blood Pressures”
Twitter
Error: Twitter did not respond. Please wait a few minutes and refresh this page.